Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2
Mirjana Urosevic, Jivko Kamarashev, Günter Burg, et al.
Blood (2003) Vol. 103, Iss. 5, pp. 1796-1798
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sun-Hwa Kim, Hiroyuki Takahashi, Wan‐Wan Lin, et al.
Nature (2008) Vol. 457, Iss. 7225, pp. 102-106
Open Access | Times Cited: 1061
HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
HLA‐G up‐regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells
Joël LeMaoult, Kamélia Zafaranloo, Caroline Le Danff, et al.
The FASEB Journal (2005) Vol. 19, Iss. 6, pp. 1-23
Closed Access | Times Cited: 289
HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism?
Nathalie Rouas‐Freiss, Philippe Moreau, Soldano Ferrone, et al.
Cancer Research (2005) Vol. 65, Iss. 22, pp. 10139-10144
Open Access | Times Cited: 241
Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors
Xunlei Kang, Jaehyup Kim, Mi Deng, et al.
Cell Cycle (2015) Vol. 15, Iss. 1, pp. 25-40
Open Access | Times Cited: 174
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133
HLA-G Molecules in Autoimmune Diseases and Infections
Roberta Rizzo, Daria Bortolotti, Silvia Bolzani, et al.
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 110
Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop
Alistair Robson, Chalid Assaf, M. Bagot, et al.
Histopathology (2014) Vol. 67, Iss. 4, pp. 425-441
Open Access | Times Cited: 99
HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia
Holger Nückel, Vera Rebmann, Jan Dürig, et al.
Blood (2004) Vol. 105, Iss. 4, pp. 1694-1698
Open Access | Times Cited: 162
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer
Chalid Assaf, Sylke Gellrich, Sean Whittaker, et al.
Journal of Clinical Pathology (2006) Vol. 60, Iss. 9, pp. 981-989
Open Access | Times Cited: 121
CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis
Ross Brown, Karieshma Kabani, James Favaloro, et al.
Blood (2012) Vol. 120, Iss. 10, pp. 2055-2063
Open Access | Times Cited: 96
HLA-G Neo-Expression on Tumors
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
Tobias Zeller, Ira A. Münnich, Roland Windisch, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses
Nathalie Rouas‐Freiss, Philippe Moreau, Catherine Menier, et al.
Seminars in Cancer Biology (2007) Vol. 17, Iss. 6, pp. 413-421
Closed Access | Times Cited: 100
Immunological aspects of pregnancy
Leona Yip, James McCluskey, Rodney Sinclair
Clinics in Dermatology (2006) Vol. 24, Iss. 2, pp. 84-87
Closed Access | Times Cited: 87
Regulation of T‐cell immunity by leucocyte immunoglobulin‐like receptors: innate immune receptors for self on antigen‐presenting cells
Katie Anderson, Rachel Allen
Immunology (2009) Vol. 127, Iss. 1, pp. 8-17
Open Access | Times Cited: 82
A New Hope for CD56negCD16pos NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases
Catherine S. Forconi, Cliff I. Oduor, Peter O. Oluoch, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 48
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer
Mi Deng, Heyu Chen, Xiaoye Liu, et al.
Antibody Therapeutics (2021) Vol. 4, Iss. 1, pp. 16-33
Open Access | Times Cited: 33
Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages
Xinyu Cao, Shen Wan, Bingyu Wu, et al.
Molecular Pharmaceutics (2025)
Closed Access
Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibition Results in Biphasic Alteration of Epidermal Homeostasis with Keratinocytic Apoptosis and Pigmentation Disorders
Karin Schad, Katrin Baumann Conzett, Marie Zipser, et al.
Clinical Cancer Research (2010) Vol. 16, Iss. 3, pp. 1058-1064
Open Access | Times Cited: 66
CD4CD56 hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype
Mirjana Urosevic, Curdin Conrad, Jivko Kamarashev, et al.
Human Pathology (2005) Vol. 36, Iss. 9, pp. 1020-1024
Closed Access | Times Cited: 66
Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia
Adriana I. Colovai, Lawrence Tsao, Su Wang, et al.
Cytometry Part B Clinical Cytometry (2007) Vol. 72B, Iss. 5, pp. 354-362
Open Access | Times Cited: 52
Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer
Pei Zhang, Xiaosun Guo, Juan Li, et al.
Oncotarget (2015) Vol. 6, Iss. 15, pp. 13550-13563
Open Access | Times Cited: 37
Inhibitory leukocyte immunoglobulin-like receptors in cancer development
Feifei Zhang, JunKe Zheng, Xunlei Kang, et al.
Science China Life Sciences (2015) Vol. 58, Iss. 12, pp. 1216-1225
Open Access | Times Cited: 37
New Insights into HLA-G and Inflammatory Diseases
Roberta Rizzo, Daria Bortolotti, Olavio R. Baricordi, et al.
Inflammation & Allergy - Drug Targets (2012) Vol. 11, Iss. 6, pp. 448-463
Closed Access | Times Cited: 36
Page 1 - Next Page

Scroll to top